These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16564525)

  • 21. Inhibition of human breast cancer cell (MBA-MD-231) invasion by the Ea4-peptide of rainbow trout pro-IGF-I.
    Siri S; Chen MJ; Chen TT
    J Cell Biochem; 2006 Dec; 99(5):1363-73. PubMed ID: 16795042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system.
    Lamy S; Lafleur R; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
    J Cell Biochem; 2007 Jan; 100(1):100-11. PubMed ID: 16823770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
    Sasaki CY; Lin H; Passaniti A
    J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator system localization in 60 cases of ductal carcinoma in situ.
    Hurd TC; Sait S; Kohga S; Winston J; Martinick M; Saxena R; Lankes H; Markus G; Harvey S; Gibbs JF
    Ann Surg Oncol; 2007 Nov; 14(11):3117-24. PubMed ID: 17701256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
    Whitley BR; Palmieri D; Twerdi CD; Church FC
    Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.
    Huang HY; Jiang ZF; Li QX; Liu JY; Wang T; Zhang R; Zhao J; Xu YM; Bao W; Zhang Y; Jia LT; Yang AG
    Cancer Invest; 2010 Aug; 28(7):689-97. PubMed ID: 20636107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
    Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ
    Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urokinase-type plasminogen activator (uPA) and its inhibitor--new prognostic factors in oral squamous cell carcinoma].
    Geleţu G; Plămădeală P; Gogălniceanu D; Zeilhofer HF; Popescu E; Moscalu M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):79-84. PubMed ID: 15688761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion.
    Frixen UH; Nagamine Y
    Cancer Res; 1993 Aug; 53(15):3618-23. PubMed ID: 8339268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
    Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness.
    Johnson MD; Torri JA; Lippman ME; Dickson RB
    Exp Cell Res; 1999 Feb; 247(1):105-13. PubMed ID: 10047452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
    Ossowski L
    Cancer Res; 1992 Dec; 52(24):6754-60. PubMed ID: 1333882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X; Egami H; Nozawa F; Abe M; Baba H
    Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
    Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK; Lim ST; Chi A; Schlaepfer DD
    Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.
    Kobayashi H; Ohi H; Sugimura M; Shinohara H; Fujii T; Terao T
    Cancer Res; 1992 Jul; 52(13):3610-4. PubMed ID: 1617632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.